ZIMVIE INC (ZIMV) Stock Fundamental Analysis
USA - NASDAQ:ZIMV - US98888T1079 - Common Stock
18.91 USD
+0.01 (+0.05%)
18.91 USD
0 (0%)
We assign a fundamental rating of 4 out of 10 to ZIMV. ZIMV was compared to 191 industry peers in the Health Care Equipment & Supplies industry. ZIMV has an average financial health and profitability rating. ZIMV is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year ZIMV was profitable.
ZIMV had a positive operating cash flow in the past year.
In the past 5 years ZIMV always reported negative net income.
In the past 5 years ZIMV always reported a positive cash flow from operatings.
1.2 Ratios
ZIMV has a Return On Assets of -2.57%. This is in the better half of the industry: ZIMV outperforms 67.02% of its industry peers.
With a decent Return On Equity value of -4.72%, ZIMV is doing good in the industry, outperforming 68.06% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 0.77%, ZIMV is in the better half of the industry, outperforming 67.02% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.57% | ||
| ROE | -4.72% | ||
| ROIC | 0.77% |
ROA(3y)-13.32%
ROA(5y)-10.87%
ROE(3y)-37.08%
ROE(5y)-25.96%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ZIMV has a Operating Margin of 1.42%. This is in the better half of the industry: ZIMV outperforms 65.97% of its industry peers.
ZIMV has a Gross Margin of 65.31%. This is in the better half of the industry: ZIMV outperforms 70.16% of its industry peers.
ZIMV's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.42% | ||
| PM (TTM) | N/A | ||
| GM | 65.31% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.03%
GM growth 5Y-1.34%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ZIMV is destroying value.
Compared to 1 year ago, ZIMV has more shares outstanding
Compared to 5 years ago, ZIMV has more shares outstanding
The debt/assets ratio for ZIMV has been reduced compared to a year ago.
2.2 Solvency
ZIMV has an Altman-Z score of 0.91. This is a bad value and indicates that ZIMV is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ZIMV (0.91) is comparable to the rest of the industry.
ZIMV has a debt to FCF ratio of 39.31. This is a negative value and a sign of low solvency as ZIMV would need 39.31 years to pay back of all of its debts.
The Debt to FCF ratio of ZIMV (39.31) is better than 67.54% of its industry peers.
A Debt/Equity ratio of 0.53 indicates that ZIMV is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.53, ZIMV is doing worse than 63.35% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 39.31 | ||
| Altman-Z | 0.91 |
ROIC/WACC0.11
WACC7.13%
2.3 Liquidity
ZIMV has a Current Ratio of 2.37. This indicates that ZIMV is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ZIMV (2.37) is comparable to the rest of the industry.
A Quick Ratio of 1.60 indicates that ZIMV should not have too much problems paying its short term obligations.
ZIMV has a Quick ratio of 1.60. This is comparable to the rest of the industry: ZIMV outperforms 45.03% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.37 | ||
| Quick Ratio | 1.6 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 135.90% over the past year.
Looking at the last year, ZIMV shows a very negative growth in Revenue. The Revenue has decreased by -50.48% in the last year.
Measured over the past years, ZIMV shows a very negative growth in Revenue. The Revenue has been decreasing by -15.69% on average per year.
EPS 1Y (TTM)135.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)-50.48%
Revenue growth 3Y-23.75%
Revenue growth 5Y-15.69%
Sales Q2Q%13.02%
3.2 Future
Based on estimates for the next years, ZIMV will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.35% on average per year.
Based on estimates for the next years, ZIMV will show a small growth in Revenue. The Revenue will grow by 0.42% on average per year.
EPS Next Y54.53%
EPS Next 2Y25.74%
EPS Next 3Y19.35%
EPS Next 5YN/A
Revenue Next Year0.03%
Revenue Next 2Y0.64%
Revenue Next 3Y0.42%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 20.55, which indicates a rather expensive current valuation of ZIMV.
ZIMV's Price/Earnings ratio is rather cheap when compared to the industry. ZIMV is cheaper than 80.10% of the companies in the same industry.
When comparing the Price/Earnings ratio of ZIMV to the average of the S&P500 Index (27.38), we can say ZIMV is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 19.93, the valuation of ZIMV can be described as rather expensive.
79.58% of the companies in the same industry are more expensive than ZIMV, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of ZIMV to the average of the S&P500 Index (22.86), we can say ZIMV is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.55 | ||
| Fwd PE | 19.93 |
4.2 Price Multiples
78.01% of the companies in the same industry are more expensive than ZIMV, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ZIMV is valued a bit cheaper than the industry average as 70.16% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 94.95 | ||
| EV/EBITDA | 16.68 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ZIMV's earnings are expected to grow with 19.35% in the coming years.
PEG (NY)0.38
PEG (5Y)N/A
EPS Next 2Y25.74%
EPS Next 3Y19.35%
5. Dividend
5.1 Amount
ZIMV does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
18.91
+0.01 (+0.05%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners90.35%
Inst Owner Change-0.12%
Ins Owners2.73%
Ins Owner Change9.43%
Market Cap533.26M
Analysts48.89
Price Target16.32 (-13.7%)
Short Float %2.73%
Short Ratio0.93
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.01%
Min EPS beat(2)21.96%
Max EPS beat(2)26.05%
EPS beat(4)4
Avg EPS beat(4)32.05%
Min EPS beat(4)1.94%
Max EPS beat(4)78.25%
EPS beat(8)6
Avg EPS beat(8)107.43%
EPS beat(12)9
Avg EPS beat(12)152.03%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.92%
Min Revenue beat(2)-3.18%
Max Revenue beat(2)1.35%
Revenue beat(4)1
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-3.62%
Max Revenue beat(4)1.35%
Revenue beat(8)2
Avg Revenue beat(8)-2.36%
Revenue beat(12)4
Avg Revenue beat(12)-1.34%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)12.04%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.5%
EPS NY rev (1m)0%
EPS NY rev (3m)8.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.3%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.55 | ||
| Fwd PE | 19.93 | ||
| P/S | 1.2 | ||
| P/FCF | 94.95 | ||
| P/OCF | 44.56 | ||
| P/B | 1.29 | ||
| P/tB | 8.87 | ||
| EV/EBITDA | 16.68 |
EPS(TTM)0.92
EY4.87%
EPS(NY)0.95
Fwd EY5.02%
FCF(TTM)0.2
FCFY1.05%
OCF(TTM)0.42
OCFY2.24%
SpS15.72
BVpS14.64
TBVpS2.13
PEG (NY)0.38
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.57% | ||
| ROE | -4.72% | ||
| ROCE | 0.97% | ||
| ROIC | 0.77% | ||
| ROICexc | 0.86% | ||
| ROICexgc | 2.21% | ||
| OM | 1.42% | ||
| PM (TTM) | N/A | ||
| GM | 65.31% | ||
| FCFM | 1.27% |
ROA(3y)-13.32%
ROA(5y)-10.87%
ROE(3y)-37.08%
ROE(5y)-25.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.03%
GM growth 5Y-1.34%
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 39.31 | ||
| Debt/EBITDA | 5.39 | ||
| Cap/Depr | 18.32% | ||
| Cap/Sales | 1.43% | ||
| Interest Coverage | 0.43 | ||
| Cash Conversion | 29.2% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.37 | ||
| Quick Ratio | 1.6 | ||
| Altman-Z | 0.91 |
F-Score6
WACC7.13%
ROIC/WACC0.11
Cap/Depr(3y)17.11%
Cap/Depr(5y)24.69%
Cap/Sales(3y)2.37%
Cap/Sales(5y)3.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)135.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y54.53%
EPS Next 2Y25.74%
EPS Next 3Y19.35%
EPS Next 5YN/A
Revenue 1Y (TTM)-50.48%
Revenue growth 3Y-23.75%
Revenue growth 5Y-15.69%
Sales Q2Q%13.02%
Revenue Next Year0.03%
Revenue Next 2Y0.64%
Revenue Next 3Y0.42%
Revenue Next 5YN/A
EBIT growth 1Y126.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year148.72%
EBIT Next 3Y45.39%
EBIT Next 5YN/A
FCF growth 1Y117.33%
FCF growth 3Y-0.91%
FCF growth 5Y-35.32%
OCF growth 1Y192.13%
OCF growth 3Y-39.59%
OCF growth 5Y-34.68%